Hyperbaric oxygen solution infused into the anterior interventricular vein at reperfusion reduces infarct size in swine

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 5 56-5, 2004, Pages

  Johnson, Lynne L ^a,c   Schofield, Lorraine ^a   Bouchard, Mark ^a   Chaves, Leonard ^a   Poppas, Athena ^a   Reinert, Steven ^a   Zalesky, Paul ^b   Creech, Jeffrey ^b   Williams, David O ^a  

^a BROWN UNIVERSITY   (United States)

^b TherOx Inc   (United States)

^c PH3 342 ^*  (United States)

Author keywords

Infarction; Ischemia

Indexed keywords

MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIFFUSION; DISEASE ASSOCIATION; ENDOCARDIUM; EPICARDIUM; FEMORAL ARTERY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE; HEMODYNAMICS; HYPERBARIC OXYGEN; INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE ACTIVATION; MALE; MONITORING; NONHUMAN; OXYGEN TENSION; PILOT STUDY; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; THORAX; VEIN;

ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HYPERBARIC OXYGENATION; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PEROXIDASE; SOLUTIONS; SWINE; VEINS; VENTRICULAR FUNCTION, LEFT;

EID: 7244257738     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00333.2003     Document Type: Article

References (32)

1. Ambrosio G, Weisman HF, Mannisi JA, and Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80:1846-1861, 1989.
2. Banick PD, Chen Q, Xu YA, and Thom SR. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J Cell Physiol 172: 12-24, 1997.
3. Black SN, Johengen MJ, Ma ZD, Bristow J, and Soifer SJ. Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs. J Clin Invest 100: 1448-1458, 1997.
4. Buras J. Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin 38: 91-109, 2000.
5. 2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis. J Pharmacol Exp Ther 279: 929-933, 1996.
6. Engler RL, Dahlgren MD, Morris DD, Peterson MA, and Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dog. Am J Physiol Heart Circ Physiol 251: H314-H322, 1986.
7. Engler RL, Schmid-Schonbein GW, and Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111: 98-111, 1983.
8. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, McCabe CH, Van De Werf F, and Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101: 125-130, 2000.
9. Hale SL, Alker KF, and Kloner RA. Evaluation of nonradioactive, colonid neurospheres for measurement of regional MBF in dogs. Circulation 78: 438-434, 1988.
10. Jeremy RW, Links JW, and Becker LC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol 16: 695-704, 1990.
11. Kloner RA. Does reperfusion injury exist in humans. J Am Coll Cardiol 21: 537-545, 1993.
12. Kloner RA, Przyklenk K, and Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Circulation 80: 1115-1127, 1989.
13. Kolodgie FD, Virmani R, and Farb A. Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%). J Am Coll Cardiol 18: 215-223, 1991.
14. Krug AW, deRochemont WM, and Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 19: 57-62, 1966.
15. Malik A and Siu K. Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol Rev 48: 213-229, 1996.
16. Mullane KM, Kraemer R, and Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14: 157-167, 1985.
17. North AJ, Lau KS, Brannon TS, Wu LC, Wells LB, German Z, and Shaul PW. Oxygen upregulates nitric oxide synthase gene expression in ovine fetal pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 270: L643-L649, 1996.
18. Ritter LS and McDonagh PF. Low-flow reperfusion after myocardial ischemia enhances leukocyte accumulation in coronary microcirculation. Am J Physiol Heart Circ Physiol 273: H1154-H1165, 1997.
19. Rochitte CE, Lima JAC, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, and Melin JA. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 98: 1006-1014, 1998.
20. Schierwagen C, Bylund-Fellenius AC, and Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 23: 179-186, 1990.
21. Shandling AH, Ellestad MH, Hart GB, Crump R, Marlow D, Van Natta B, Messenger JC, Strauss M, and Stavitsky Y. Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study. Am Heart J 134: 544-550, 1997.
22. Spears JR, Henney C, Prcevski P, Xu R, Li L, Brereton GJ, DiCarli M, Spanta A, Crilly R, Sulaiman AM, Hudeed S, Lavine S, Patterson WR, Creech J, and Vander Heide R. Aqueous oxygen hyperbaric reperfusion in a porcine model of myocardial infarction. J Invas Cardiol 14: 160-166, 2002.
23. 2-supersaturated infusate for regional correction of hypoxemia and production of hyperoxemia. Circulation 96: 4385-4391, 1997.
24. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multi-step paradigm. Cell 76: 301-314, 1994.
25. Stavitsky Y, Shandling AH, Ellestad MH, Hart GB, Van Natta B, Messenger JC, Strauss M, Dekleva MN, Alexander JM, Mattice M, and Clarke D. Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" randomized multicenter study. Cardiology 90: 131-136, 1998.
26. Sterling DL, Thornton JD, Swafford A, Gottlieb SF, Bishop SP, Stanley AW, and Downey JM. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation 88: 1931-1936, 1993.
27. Sunami K, Takeda Y, Hashimoto M, and Hirakawa M. Hyperbaric oxygen reduces infarct volume in rate by increasing oxygen supply to the ischemic periphery. Crit Care Med 28: 2831-2836, 2000.
28. Thom S. Functional inhibition of leukocyte β2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol Appl Pharmacol 123: 248-256, 1993.
29. Thom SR and Elbuken ME. Oxygen-dependent antagonism of lipid peroxidation. Free Radic Biol Med 10: 413-426, 1991.
30. 2. Am J Physiol Cell Physiol 272: C770-C777, 1997.
31. Thomas MP, Brown LA, Sponseller DR, Williamson SE, Diaz JA, and Guyton DP. Myocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator. Am Heart J 120: 791-800, 1990.
32. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, and Lima JA. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97: 765-772, 1998.